Brief: Inflarx Receives FDA Emergency Use Authorization For Gohibic

Inflarx NV

04/04/2023 20:01

April 4 (Reuters) - InflaRx NV  IF0G.F :
    * INFLARX RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR
GOHIBIC
(VILOBELIMAB) FOR TREATMENT OF CRITICALLY ILL COVID-19 PATIENTS
    * INFLARX NV - CONTINUES DIALOGUE WITH FDA TO DISCUSS NEXT
STEPS
TOWARDS A BIOLOGICS LICENSE APPLICATION SUBMISSION FOR FULL
APPROVAL
    * INFLARX NV- ENCOURAGING PRE-SUBMISSION MEETINGS HELD WITH
EMA IN
EUROPE; PLANS TO APPLY FOR FULL APPROVAL TO TREAT CRITICALLY ILL
COVID-19 PATIENTS

Source text for Eikon:  ID:nGNX4RWNYq 
Further company coverage:  IF0G.F 

 ((Reuters.Briefs@thomsonreuters.com;))